Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required)

Overview

A technical help webinar was held for potential candidates of the next Discover of Funding Alternative (NOFO): Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Medical Excessive Threat for Psychosis Medical Trial Community (U01 Medical Trial Required) . Nationwide Institute of Psychological Well being workers answered questions associated to this NOFO.

The aim of this NOFO is to assist one scientific trial community to guage organic, digital, cognitive, and scientific end result measures in people at scientific excessive danger (CHR) for psychosis in Proof of Precept (PoP) trial(s) utilizing a pharmacological intervention. Distinctive drug growth instruments developed by means of AMP® SCZ initiative will probably be evaluated within the PoP trial(s). The compound(s) chosen for testing by the AMP SCZ Steering Committee will have an effect on a pathophysiologically related mechanism and have the potential to provide a detectable sign on organic, digital, cognitive, or scientific end result measures inside a 12-16 week interval of research.

Recording

Learn the transcript.

Sponsored by

Division of Translational Analysis

Contact

Jonathan Sabbagh, Ph.D.    
jonathan.sabbagh@nih.gov

Leave a Reply

Your email address will not be published. Required fields are marked *

WC Captcha 96 − 91 =

Contact Us

Give us a call at (385) 312-0787  or fill in the form below and we will contact you. We endeavor to answer all inquiries within 24 hours on business days.